Novocure Ltd Ord Sh (NVCR)
18.29 -0.02 (-0.11%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 18.29 unch (unch) 16:33 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NVCR | MIRM | BEAM | ||
| Company | Novocure Ltd Ord Sh | Mirum Pharmaceuticals Inc | Beam Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.32 | 41.05 | 19.80 | ||
| High | 18.52 | 42.96 | 20.19 | ||
| Low | 17.68 | 40.29 | 19.28 | ||
| Last | 18.29 | 42.54 | 19.71 | ||
| Change | -0.02 | +1.23 | -0.09 | ||
| % Change | -0.11% | +2.98% | -0.45% | ||
| Volume | 723,600 | 444,100 | 1,536,200 | ||
| 20-Day Average Volume | 885,340 | 448,385 | 2,745,110 | ||
| Previous Close | 18.31 | 41.31 | 19.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.92 | 40.67 | 17.42 | ||
| 20-Day Raw Stochastic | 78.47% | 64.46% | 84.91% | ||
| 20-Day Relative Strength | 49.72% | 49.61% | 47.75% | ||
| Weighted Alpha | -14.40 | +42.38 | -12.11 | ||
| Today's Opinion | 64% Sell | 40% Sell | 88% Sell | ||
| Previous Opinion | 64% Sell | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 56% Sell | 40% Buy | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.78% since 04/22/25 | +7.89% since 04/22/25 | +3.03% since 04/22/25 | ||
| Low | 16.94 on 04/23/25 | 39.18 on 04/23/25 | 19.28 on 04/29/25 | ||
| High | 19.25 on 04/24/25 | 42.96 on 04/29/25 | 20.81 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -3.02% since 03/28/25 | -7.50% since 03/28/25 | -11.26% since 03/28/25 | ||
| Low | 14.81 on 04/09/25 | 36.88 on 04/09/25 | 13.52 on 04/07/25 | ||
| High | 19.25 on 04/24/25 | 45.71 on 03/31/25 | 21.38 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -28.33% since 01/29/25 | -12.47% since 01/29/25 | -23.93% since 01/29/25 | ||
| Low | 14.81 on 04/09/25 | 36.88 on 04/09/25 | 13.52 on 04/07/25 | ||
| High | 26.47 on 01/30/25 | 54.23 on 02/21/25 | 35.25 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | +8.29% since 10/29/24 | +8.91% since 10/29/24 | -11.10% since 10/29/24 | ||
| Low | 14.81 on 04/09/25 | 36.88 on 04/09/25 | 13.52 on 04/07/25 | ||
| High | 34.13 on 12/18/24 | 54.23 on 02/21/25 | 35.25 on 02/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,041,309 | 2,042,944 | 1,991,028 | ||
| Shares Outstanding, K | 111,486 | 49,454 | 100,557 | ||
| Annual Sales | 605,220,000 | 336,890,000 | 63,520,000 | ||
| Annual Net Income | -168,630,000 | -87,940,000 | -376,740,000 | ||
| Last Quarter Sales | 154,990,000 | 99,410,000 | 30,070,000 | ||
| Last Quarter Net Income | -34,320,000 | -23,790,000 | -90,350,000 | ||
| 60-Month Beta | 0.65 | 1.00 | 2.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 04/24/25 | -0.49 on 02/26/25 | -1.09 on 02/25/25 | ||
| Latest Earnings Date | 04/24/25 | 05/14/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/04/14 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||